Development of JNJ-64158120, an anti-TIM-3 antibody to overcome innate and acquired mechanisms of resistance to PD-1 therapy
Nikki DeAngelis,Gordon Powers,Keri Dorn, Matthew Chomo, Douglas Dolfi,Karla Wiehagen, Douglas Marvel,Bethany Mattson,Darlene Pizutti,Liam Campion,Caitlin Morgan, Brian Tomkowicz,Nina Sabins,Sandra Santulli-Marotto,Jocelyn Sendecki,John Wheeler,Brian Whitaker,Annmarie Winkis,Linda Barone,Deborah Kwok,Eilyn R. Lacy,Edmund Moon, Steve Albelda,Kathryn Packman,Enrique Zudaire,Matthew V. Lorenzi,Raluca I. Verona JOURNAL FOR IMMUNOTHERAPY OF CANCER（2017）
AI 理解论文
溯源树
样例
